900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Insulin isophane biphasic human 10/90 100units/ml injection 1.5ml cartridge	Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 10/90 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial	Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 20/80 100units/ml injection 3ml cartridge	Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial	Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 30/70 100units/ml injection 10ml vial	Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge	Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 40/60 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial	Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge	Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial	Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial	Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug)
bovint isofaninsulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml	Bovine isophane insulin 100 unit/mL suspension for injection
porcint isofaninsulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml	Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
porcint isofaninsulin, 100 E/ml, injektionsvätska, lösning, flaska 10 ml	Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane porcine 100units/ml injection 10ml vial	Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge	Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)
porcint lösligt insulin, 100 E/ml, injektionsvätska, lösning, cylinderampull 1,5 ml	Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug)
biverkning av amorf zinkinsulinsuspension	Adverse reaction to zinc insulin
biverkning av kristallin zinkinsulinsuspension	Adverse reaction to zinc insulin
allergi mot kristallin zinkinsulinsuspension	Allergy to zinc insulin
biverkning av zinkinsulinsuspension	Adverse reaction to zinc insulin
Intact parathyrin	Parathyroid hormone
intag	Introduction procedure (procedure)
integrerad muskuloskeletal frigöring	Osteopathic combined treatment method (procedure)
syndrom med intellektuell funktionsnedsättning, katarakt och kyfos	Congenital disorder of glycosylation type 1q (disorder)
Intentional X-ray contrast media overdose	Intentional X-ray diagnostic contrast media overdose
Intentional X-ray contrast media poisoning	Intentional X-ray diagnostic contrast media overdose
avsiktlig överdos av disulfiram	Intentional disulfiram overdose (disorder)
avsiktlig disulfiramförgiftning	Intentional disulfiram poisoning (disorder)
Intentional chlorprothixene overdose	Intentional chlorprothixene overdose (disorder)
avsiktlig överdos av natriumvalproat	Intentional valproate overdose (disorder)
Intentional pesticide product overdose	Intentional pesticide product poisoning
avsiktlig överdos av natriumfusidat	Intentional fusidic acid overdose
avsiktlig warfarinöverdos	Intentional warfarin overdose (disorder)
Intentional zuclopenthixol overdose	Intentional chlorprothixene overdose (disorder)
Interdigital pilonidal sinus	Barber's pilonidal sinus
interferon alfa-2b 10 miljoner IE, pulver och vätska till injektionslösning, flaska	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 10 miljoner IE, pulver till injektionsvätska, lösning, flaska	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 10 miljoner IE/ml, injektionsvätska, lösning, flaska 2,5 ml	Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)
interferon alfa-2b 18 miljoner IE/flaska, lösning	Interferon alfa-2b only product
Interferon alfa-2b 18million/iu solution	Interferon alfa-2b only product
Interferon alfa-2b 18mu/vial	Interferon alfa-2b only product
interferon alfa-2b 25 miljoner IE/flaska, lösning	Interferon alfa-2b only product
interferon alfa-2b 3 miljoner IE/flaska, lösning	Interferon alfa-2b only product
interferon alfa-2b 30 miljoner IE, lösning	Interferon alfa-2b only product
interferon alfa-2b 3 miljoner IE, pulver och vätska till injektionslösning, flaska	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 3 miljoner IE, pulver till injektionsvätska, lösning, flaska	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 5 miljoner IE/flaska, lösning	Interferon alfa-2b only product
interferon alfa-2b 5 miljoner IE, pulver och vätska till injektionslösning, flaska	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 5 miljoner IE, pulver till injektionsvätska, lösning, flaska	Interferon alfa-2b only product in parenteral dose form
interferon alfa-2b 60 miljoner IE, lösning	Interferon alfa-2b only product
interferon alfa-n3 från humana leukocyter 5 miljoner enheter/ml, injektionsvätska, lösning, flaska 1 ml	Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug)
interferon beta-1a 12 miljoner IE/ml, injektionslösning, förfylld spruta 0,5 ml	Interferon beta-1a 30 microgram/mL solution for injection
interferon beta-1a 24 miljoner IE/ml, injektionslösning, förfylld spruta 0,5 ml	Interferon beta-1a 24 million unit/mL solution for injection
Interferon beta-1a 30mcg/vial injection	Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug)
interferon beta-1a 30 mikrogram/injektionsflaska, injektionsvätska, lösning	Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug)
interferon beta-1a 6 miljoner IE, pulver och vätska till injektionslösning, flaska	Interferon beta-1a only product in parenteral dose form
interferon beta-1a 6 miljoner IE, pulver till injektionsvätska, lösning, flaska	Interferon beta-1a only product in parenteral dose form
interferon beta 1-b 100 mikrogram, injektionsvätska, lösning	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
interferon beta-1b 8 miljoner IE, pulver och vätska till injektionslösning, flaska	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
interferon beta-1b 8 miljoner IE, pulver till injektionsvätska, lösning, flaska	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
interimsrapport	Interim report (record artifact)
intermediär faktor VIII-fraktion, 250 IE, pulver och vätska till injektionslösning, flaska	Coagulation factor VIII only product
intermediär faktor VIII-fraktion, 500 IE, pulver och vätska till injektionslösning, flaska	Coagulation factor VIII only product
Intermediate lobe of right lung	Structure of middle lobe of right lung (body structure)
Angiography of internal carotid arteries, bilateral	Angiography of cervicocerebral arteries
intermediär metaboliserare på grund av cytokrom p450, variant CYP2C19	CYP2C19 intermediate metabolizer
intermediär metaboliserare på grund av cytokrom P450, variant CYP2D6	Cytochrome P450 family 2 subfamily D member 6 intermediate metabolizer (finding)
intermittent CPAP-behandling	Positive pressure ventilation
Intermittent positive pressure ventilation	Positive pressure ventilation
ventilation med intermittent positivt tryck	Positive pressure ventilation
intermittent övertrycksventilation via blåsa och mask	Positive pressure ventilation via bag and mask (regime/therapy)
intermittent övertrycksventilation via endotrakealtub	Positive pressure ventilation via endotracheal tube
intern fixering av underkäken med bågstänger	External fixation of mandible with arch bars (procedure)
Internal fixation of mandible with arch bars	External fixation of mandible with arch bars (procedure)
Internal granuloma of pulp	Internal resorption of tooth
intern migration	Transuterine migration (finding)
musculus obliquus internus abdominis-lambå	Internal oblique muscle flap
Internal resorption of crown of tooth	Internal resorption of tooth
Internal unsealed radiotherapy NOS	Radionuclide therapy
Internal unsealed radiotherapy NOS	Radionuclide therapy
cervixcancer FIGO-stadium IA1	IA1
cervixcancer FIGO-stadium IA2	IA2
cervixcancer FIGO-stadium IB1	IB1
cervixcancer FIGO-stadium IB2	IB2
cervixcancer FIGO-stadium IIA1	IIA1
cervixcancer FIGO-stadium IIA2	IIA2
cervixcancer FIGO-stadium IIB	American Joint Committee on Cancer stage IIB (qualifier value)
cervixcancer FIGO-stadium IIIA	American Joint Committee on Cancer stage IIIA (qualifier value)
cervixcancer FIGO-stadium IIIB	American Joint Committee on Cancer stage IIIB (qualifier value)
cervixcancer FIGO-stadium IVA	American Joint Committee on Cancer stage IVA (qualifier value)
cervixcancer FIGO-stadium IVB	IVB
cervixcancer FIGO-stadium 0	Carcinoma in situ of uterine cervix
cervixcancer FIGO-stadium I	I
cervixcancer FIGO-stadium II	American Joint Committee on Cancer stage II (qualifier value)
cervixcancer FIGO-stadium III	American Joint Committee on Cancer stage III (qualifier value)

Start Previous Page 63 of 153 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)